(Q33708237)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10442233%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

review article

1 reference

title

Pharmacotherapy in children and adolescents with obsessive-compulsive disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10442233%20AND%20SRC:MED&resulttype=core&format=json

obsessive-compulsive disorder

11 December 2019

main subject

pharmacotherapy

0 references

1 reference

Grados M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10442233%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Scahill L

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10442233%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Riddle MA

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10442233%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10442233%20AND%20SRC:MED&resulttype=core&format=json

Child and Adolescent Psychiatric Clinics of North America

11 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10442233%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10442233%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10442233%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

617-34, x

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10442233%20AND%20SRC:MED&resulttype=core&format=json

Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Current knowledge of medications for the treatment of childhood anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

A case report of risperidone-induced obsessive-compulsive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. AACAP

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Clomipramine: an antiobsessive drug

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Clomipramine in obsessive-compulsive disorder: A review

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Dopamine blocking activity of clomipramine in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Physical symptoms associated with paroxetine discontinuation

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

The benefits of clomipramine-fluoxetine combination in obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Treatment of risperidone-induced obsessive-compulsive symptoms with sertraline.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Childhood obsessive-compulsive disorder: a prospective follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Clonazepam in childhood anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Seizure associated with fluoxetine and adjuvant buspirone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Cognitive-behavioral psychotherapy for children and adolescents with OCD: a review and recommendations for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Trichotillomania and related disorders in children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Effects of meta-chlorophenylpiperazine on cerebral blood flow in obsessive-compulsive disorder and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Obsessive-compulsive disorder and serotonin: is there a connection?

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Tricyclic response in obsessive compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

The diagnosis and psychopharmacological treatment of trichotillomania: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Concomitant obsessive-compulsive disorder and schizotypal personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Open trial of fluoxetine in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Obsessive-compulsive disorders in the pediatric dermatology practice

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Pulse loading versus gradual dosing of intravenous clomipramine in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Symptoms of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Rates of Obsessive Compulsive Disorder in First Degree Relatives of Patients with Trichotillomania: a Research Ndte

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Clonazepam as an augmenting agent in the treatment of childhood-onset obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramine

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol-driven treatment package.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? II.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Erythromycin and clomipramine: noncompetitive inhibition of demethylation

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

A family study of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Fluoxetine-induced movement disorders and deficient CYP2D6 enzyme activity

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Drug utilization review of concomitant use of specific serotonin reuptake inhibitors or clomipramine with antianxiety/sleep medications

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Fluoxetine overdose in an adolescent

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Another sudden death in a child treated with desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: preliminary clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Fluoxetine treatment of obsessions and compulsions in patients with Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Obsessive compulsive disorder in children and adolescents: phenomenology and family history

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Behavioral therapy in children and adolescents with obsessive-compulsive disorder: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

A comparison of clinical features in trichotillomania and obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Use of clomipramine in treatment of obsessive-compulsive symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Obsessive-compulsive disorder in children and adolescents. Clinical phenomenology of 70 consecutive cases

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Child and adolescent obsessive-compulsive disorder treated with citalopram: findings from an open trial of 23 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Clomipramine and imipramine in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Clonazepam-induced up-regulation of serotonin1 binding sites in frontal cortex of rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

The use of intravenous chlorimipramine in the treatment of obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Serotonin-uptake inhibitors in obsessive-compulsive disorder: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Fluoxetine and bleeding in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1056-4993%2818%2930171-8

7 January 2021

10.1016/S1056-4993(18)30171-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10442233%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference